Summary
The present experiments were carried out to investigate the cardiovascular effects of endothelin 1 (ET) in pithed spontaneously hypertensive (SH) rats and to evaluate its mechanism of action. The results show that ET (0.1 – 3 nmol/kg i.v.) is a powerful vasoconstrictor agent in the pithed rat. However, at a dose of 3 nmol/kg i.v. all the pithed animals “died” following a gradual decrease in mean arterial blood pressure and pulse pressure and changes in the form of the electrocardiogram (ECG). The predominant feature of the change in the ECG was a progressive decrease in the amplitude of the T wave resulting in a depression of the curve representing repolarization. Investigations in isolated perfused SH rat hearts showed that ET powerfully reduces coronary flow concentration-dependently (IC50 2.1 ±0.3 nM) an effect associated with sinus bradycardia and a decrease in coronary pressure amplitude. No overt ECG changes were seen. Control experiments with mechanical flow restriction suggest that bradycardia is a consequence of reduced coronary flow and that the ECG changes observed in vivo can be explained on the basis of coronary insufficiency and resulting myocardial hypoxia. Vasoconstrictor responses to angiotensin II (0.4 μg/kg i.v.), phenylephrine (8 μg/kg i.v.) and ET (0.5 nmol/kg i.v.) were antagonised by around 70% by isradipine (0.03 mg/kg i.a.). The results suggest that endothelin-induced vasoconstriction may involve receptor operated channel activation and opening of voltage sensitive Ca2+ channels.
Similar content being viewed by others
References
Änggård E, Galton S, Ree G, Thomas R, Mcloughlin L, de Nucci G, Vane JR (1989) The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol 13 (Suppl) 5:46–48.
Budden R, Buschmann G, Kühl UG (1981) The rat ECG in acute pharmacology and toxicology. In: Budden R, Detweiler DK, Zbinden G (eds) The electrocardiogram in pharmacology and toxicology. Pergamon, Oxford.
Cook NS, Quast U, Hof RP, Baumlin Y, Pally C (1988) Similarities in the mechanism of action of two new vasodilator drugs: Pinacidil and BRL 34915. J Cardiovasc Pharmacol 11:90–99.
De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci 85:9797–9800.
Gillespie JS, Muir TC (1967) A method of stimulating the complete sympathetic outflow from the spinal cord to the blood vessels in the pithed rat. Br J Pharmacol 30:78–87.
Hu JR, Harsdorf RV, Lang RE (1988) Endothelin has potent inotropic effects in rat atria. Eur J Pharmacol 158:275–278.
Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T (1988) Positive inotropic action of a novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 255 Heart Circ Physiol 24:H970–973.
Lee CY, Chiappinelli VA (1988) Similarity of endothelin to snake venom toxin. Nature 335:303.
Lee SY, Lee CY, Chen YM, Kochva E (1986) Coronary vasospasm as the primary cause of death due to the venom of the burrowing aps, Atractaspis Engaddensis. Toxicon 24:285–291.
Shipley RE, Tilden JH (1947) A pithed rat preparation suitable for assaying pressor substances. Proc Soc Exp Med 64:453–455.
Spokes RA, Bretherton-Watt D, Ghatei MA, Bloom SR (1989) Endothelin infusion in the anaesthetized rat: plasma endothelin concentrations and blood pressure changes. Br J Pharmacol 96:107P.
Takasaki M, Kimura S, Goto K, Masaki T (1988) Similarity of endothelin to snake venom toxin. Nature 335:303.
Van Renterghem C, Vigne P, Barhanin J, Schmid-Alliana A, Frelin C, Lazdunski M (1988) Molecular mechanism of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun 157:977–986.
Wallnöfer A, Weir S, Rüegg U, Cauvin C (1989) The mechanism of action of endothelin as compared with other agonists in vascular smooth muscle. J Cardiovasc Pharmacol 13 (suppl) 5:23–31.
Wollberg Z, Shabo-Shiva R, Intrator N, Bdolah A, Kochva E, Shavit G, Ornon X, Vidne BA, Girtters (1988) A novel cardiotoxic polypeptide from the venom of Atractaspis Engaddensis (burrowing asp): cardiac effects in mice and isolated rat and human heart preparations. Toxicon 26:525–534.
Wright CE, Fozard JR (1988) Regional vasodilatation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. Eur J Pharmacol 155:201–203.
Yanagisawa M, Inoue A, Ishikawa T (1988a) Primary structure, synthesis, and biological activity of rat endothelin, an endothelium derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85:6964–6967.
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988b) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415.
Author information
Authors and Affiliations
Additional information
Send offprint requests to A. K. Mir at the above address
Rights and permissions
About this article
Cite this article
Mir, A.K., Berthold, H., Scholtysik, G.E. et al. Cardiovascular effects of endothelin 1 in pithed spontaneously hypertensive rats: evaluation of its mechanism(s) of action. Naunyn-Schmiedeberg's Arch Pharmacol 340, 424–430 (1989). https://doi.org/10.1007/BF00167044
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00167044